Clinical Trials Browser

Phase 2/3 × INDUSTRY × lutetium Lu 177 dotatate × Clear all

NCT06398444 2025-09-05

A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms

Phase 2/3 Active not recruiting

Advanced Neuroendocrine Neoplasm